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Site-specific integration in CHO cells
mediated by CRISPR/Cas9 and
homology-directed DNA repair pathway
Jae Seong Lee, Thomas Beuchert Kallehauge, Lasse Ebdrup Pedersen & Helene Faustrup Kildegaard
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2970 Hørsholm, Denmark.
Chinese hamster ovary (CHO) cells are the most widely used mammalian hosts for production of
therapeutic proteins. However, development of recombinant CHO cell lines has been hampered by unstable
and variable transgene expression caused by random integration. Here we demonstrate efficient targeted
gene integration into site-specific loci in CHO cells using CRISPR/Cas9 genome editing system and
compatible donor plasmid harboring a gene of interest (GOI) and short homology arms. This strategy has
enabled precise insertion of a 3.7-kb gene expression cassette at defined loci in CHO cells following a simple
drug-selection, resulting in homogeneous transgene expression. Taken together, the results displayed here
can help pave the way for the targeting of GOI to specific loci in CHO cells, increasing the likelihood of
generating isogenic cell lines with consistent protein production.
C
hinese hamster ovary (CHO) cells have been used as the predominant workhorses for production of
recombinant therapeutic proteins with complex glycoforms1,2. Traditionally, development of recombin-
ant CHO (rCHO) cell lines relies on random integration of a gene of interest (GOI) into the genome,
followed by selection of cells carrying the transgene1,2. However, lack of control of gene insertion can give rise to
unwanted phenotypic heterogeneity due to the varying accessibility of integration sites for gene expression –
termed the position effect variation2,3. In addition, gene amplification methods are traditionally used to increase
expression. As a result, these cell lines are often unstable and show reduced production over time4. Due to this
variation in expression and genomic composition, subsequent screening of multiple clones is necessary to select
proper clones suitable for high and stable expression of recombinant proteins1,2. In this article, we show that
targeting of transgenes into specific desirable sites in the CHO genome in a controlled manner reduces the
variation in expression, generating a uniform population with stable transgene expression.
In order to circumvent uncontrollable gene insertion during rCHO cell line construction, different approaches
have been applied for site-directed integration of transgenes using site-specific recombinases, which includes Cre/
loxP system, Flp/FRT system, and phiC31/R4 integrases5–7. However, these systems are limited by the need of a
prior establishment of platform cell lines with the insertion of recombination site into random or a limited
number of specific genomic regions, which is a prerequisite for retargeting to generate cell lines expressing the
GOI.
With draft genomes of several CHO cell lines recently being made available8,9, it is now possible to efficiently
engineer the genomic sequence of CHOcells with engineered nucleases. Customized nucleases such as zinc-finger
nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced
short palindromic repeats (CRISPR)-associated (Cas) RNA guided nucleases are technologies readily available to
induce targeted insertion/deletion (indel) mutations or precise sequence changes in a broad range of organisms
and cell types (reviewed in Ref. 10). Upon site-specific DNA double-strand breaks (DSBs) induced by engineered
nucleases, the target locus will typically be repaired by one of two major DNA damage repair pathway: non-
homologous end-joining (NHEJ) or homology-directed repair (HDR). Compared with the error-prone NHEJ,
which can result in efficient indelmutation generation subsequently leading to knockout of target locus, HDR can
be used to modify endogenous loci precisely in the presence of homologous pieces of endogenous/exogenous
DNA. Although HDR is typically observed at a lower or more variable frequency than NHEJ, HDR can be
leveraged to generate targeted integrations with engineered nucleases inmammalian cells11–15. Notably, CHOcells
have previously been described as a cell type recalcitrant to homology-based integration of large DNA constructs,
thus targeted integration in CHO cells has been confined to NHEJ based approaches16,17.
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Compared with protein-based genome editing tools with custo-
mizable DNA binding specificities, such as ZFNs and TALENS, the
newer CRISPR/Cas9 platform is based on simple base-pairing
between an engineered RNA and the targeted genomic site, which
enables rapid design, ease of use, and low costs18. The CRISPR/Cas9
system, which was initially identified in the bacterial immune system,
is composed of two RNA elements, CRISPR-RNA (crRNA) and trans-
activating crRNA (tracrRNA), together with the Cas9 nuclease14,19.
The active cleavage-complex is generated by base-pairing between
the genomic sequence and crRNA, followed by hybridization of the
tracrRNA to the crRNA. Subsequently, the Cas9 nuclease associates
with the DNA:RNA complex to form the active cleavage complex,
which in turn will generate site specific DSBs at the genomic locus19.
In recent studies, the original type II CRISPR system from S. pyogenes
was modified to induce targeted genome editing in eukaryotic cells by
fusing the two RNA complexes termed single guide RNA (sgRNA)11,14,19.
We previously developed a CRISPR/Cas9 system optimized for CHO
cells, and demonstrated high efficiency of indels generated in CHO cells
up to 47.3%20. Assuming that the high rate of DSB introduction will
induce DNA damage repair pathways, and the concurrent introduction
of a donor plasmid will be used as the repair template, the targeted
integration at specific genomic sites can be feasible with high fidelity.
Here we demonstrate efficient targeted gene integration into site-
specific loci in CHO cells using CRISPR/Cas9 genome editing system
and compatible donor plasmid harboring short-homology arms,
GOI, and a fluorescent marker gene as an indicator of random integ-
ration. Simultaneous introduction of active sgRNAs, Cas9 nucleases,
and donor plasmid enabled insertion of a 3.7-kb gene expression
cassette at three different loci in CHO cells, following a simple
drug-selection. A low level of off-target mutation in most potential
off-target sites and homogeneous expression level of GOI was
observed in targeted integrants, which supports the robustness and
efficiency of the current strategy.
Results
Development of a HDR mediated targeted integration platform
for CHO. To facilitate improved construction of rCHO cell lines, we
aimed at developing a CRISPR and HDR mediated targeted integra-
tion system to obtain controlled and precise integration of transgenes.
The system is based on donor plasmids harboring short homology
arms, which flank the Cas9 cleavable sgRNA target site, used as the
integration sites (Fig. 1a). The donor plasmids were constructed as
follows: Regardless of loci and sgRNAs, the homology arms were
designed to be exactly next to the whole 23 bp of sgRNA genomic
target sequences (Supplementary Table 1). The length of each 59 and
39 homology arm was set at 750 bp unless otherwise mentioned. An
mCherry expression cassette and a neomycin resistance gene expres-
sion cassette were placed within the homology arms. A ZsGreen1-DR
expression cassette was placed outside the homology arms to detect
random integration events. Upon correct targeting of the donor
plasmids to the desired locus via HDR, cells will lose ZsGreen1-DR
expression and only express mCherry together with neomycin resis-
tance. If cells express both mCherry and ZsGreen1-DR after neomycin
selection, random integration of the donor plasmid has occurred. This
assumption was applied in order to enrich for targeted integrants by
excluding clones expressing ZsGreen1-DR. To evaluate correct inte-
gration byHDR, 59/39 junction PCR amplicons were designed for each
target site (Fig. 1a). We targeted a total of four sites in three different
genomic loci of CHO cells; one site in C1GALT1C1 (COSMC) encod-
ing the C1GALT1-specific chaperone 1, two sites in Mgat1 encoding
the mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyl-
transferase, and one site in LdhA encoding the lactate dehydrogenase A.
Precise targeted integration of transgene at the COSMC locus
in CHO cells. The COSMC locus has previously been effectively
modified by CRISPR/Cas9 system in CHO cells20. Thus, this locus
was chosen for initial validation of the targeted integration strategy.
The region targeted by sgRNA2, which gave rise to high indel
efficiency in CHO-K1 cells in our previous study20, was selected as
the integration site. Based on this site, 59 and 39 homology arms were
designed to generate the targeting donor plasmid (Fig. 1a). CHO-S
cells were transfected with the vectors encoding CHO codon opti-
mized Cas9, COSMC sgRNA2, and donor plasmid. Genomic DNA
was extracted either three days after transfection (transient expression)
or two weeks after G418 selection (stable expression). No integration
events were detected in the transiently transfected pools by the 59/39
junction PCR (Fig. 1b, Lane 1–5). In the stable selected pools, both 59
and 39 junction PCR verified targeted integration of donor DNA into
the COSMC locus (Fig. 1b, Lane 7 and 10). In agreement with a
previous observation16, linearization of the donor DNA outside of
the homology arms resulted in fainter PCR positive bands from 59/
39 junction PCR compared with those from circular donor DNA
(Fig. 1b, Lane 8 and 11). Stepwise decreasing the length of 59 and 39
homology arms flanking the same COSMC integration site from
750 bp to 100 bp indicated that homology arms with a length down
to 250 bp were capable of mediating homology-based targeted
integration, although the PCR band intensity was gradually
decreased (Supplementary Fig. 1). In accordance with the
assumption that cells expressing both ZsGreen1-DR and mCherry
were the result of random integration, stable cells expressing both
mCherry and ZsGreen1-DR, which were isolated by FACS, showed
incomplete and faint junction PCR positive bands indicating a
mixture of integration events. (Fig. 1b, Lane 13 and 15). To verify
precise integration into the genome, the 59/39 genome-donor
boundaries were sequenced (Fig. 1c). Indeed, the sequences of the
59/39 junction PCR amplicons confirmed precise insertion of the
target expression cassette into the COSMC locus. We then screened
588 G418-resistant clones and isolated 138 clones, which displayed
homogeneous expression of mCherry. 23 clones were excluded due to
very slow growth resulting in 115 clones, which were further
characterized. 83 out of 115 (72.2%) were 59/39 junction PCR
positive (Table 1). Out-out PCR with primers specific for genomic
sites revealed that 70 out of 83 junction PCR positive clones (84.3%,
i.e. 60.9% in total) were correctly targeted with the intact target
integration unit, generating expected size of amplicon (wild type
amplicon: 1.6 kb 1 target integration unit: 3.7 kb < 5.3 kb; Fig. 1d,
Lane 4, Table 1). As a result, a targeting efficiency of 27.8% was
obtained based on the percentage of out-out PCR positive clones in
mCherry only expressing clones and a proportion of the mCherry only
expressing cells in the stable cell pool (Table 1). These 70 out-out PCR
positive clones were expanded and adapted to grow in suspension. A
total of 45 clones were recovered, followed by further characterization.
42 out of 45 clones had complete disruptions of the COSMC locus, as
indicated by qPCR-based relative copy number analysis compared with
genomic DNA from CHO-S wild type cells (Fig. 1e, left panel).
Assuming that gene copies must be integer values, the value of
relative copy number is expected to be 0, 0.5, or 1 for targeted clonal
cells. Three clones without these values were therefore not considered
as clonal cells. Relative mCherry copy number result amongst selected
clones revealed that most clones harbored the same number of
mCherry transgene, except two clones with 2- or 3-fold higher
number (Fig. 1e, right panel). Successful targeting of transgenes at
the COSMC locus validated our integration method, and prompted
us to apply to different genomic loci showing distinct properties.
Application of targeted integration platform to the functional hemi-
zygous locus, Mgat1. TheMgat1 locus was selected as a second inte-
gration site to test the applicability of the targeted integration system
at a different genomic locus. Some CHO cell lines contain one func-
tionalMgat1 allele that renders this locus more prone to be disrupted
by chemical mutagenesis or genome editing tools, leading to func-
tional knockout of Mgat121,22. Since Mgat1 adds N-acetylglucosamine
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8572 | DOI: 10.1038/srep08572 2
ab
c
Reference
Conservaon
5’ juncon 3’ juncon
Target locus:
sgRNA
Target
(23 bp)
////
// 5’ arm SV40 Neo(R) SV40 pABGH pAEF1α mCherry 3’ arm CMV BGH pAZsGreen1 //Donor:
3.7 kb
HDR
5’ arm SV40 Neo(R) SV40 pABGH pAEF1α mCherry 3’ arm// //
Out
In
In
Out
5’ juncon 3’ juncon
Transient Stable
- + - + +
- - + + +
+ +
- +
- - + + +M M - + M
+
+
+
+ +
- +
- + M
+
+
+
5’ juncon 3’ juncon
*
Cas9
Donor
COSMC sgRNA2
+ +
+ -
+ - M
+
+
+
3’ juncon
+
-
- M
5’ juncon
Stable 
[mCherry+ / ZG1+]
1000bp
1500bp
*
1 2 3 4 5 6 7 8 9 10 11
1000bp
1500bp
12 13 14 15
*
d
+ + + +
- + + +
- + + +
M
Cas9
Donor
COSMC sgRNA2
1500bp
6000bp
5000bp
Pool Clone
- + - +Juncon PCR
1 2 3 4
e
Re
la
v
e 
CO
SM
C 
co
py
 n
um
be
r
0.0
0.2
0.4
0.6
0.8
1.0
1 2 3 4 5 6 8 11 12 13 14 16 18 19 20 23 26 28 33 37 38 39 42 44 45 47 50 51 52 53 56 57 58 61 62 63 64 65 69 77 81 84 86 10
6
10
8
CH
O
-S
Re
la
v
e 
m
Ch
er
ry
 c
op
y 
nu
m
be
r
0
1
2
3
4
5
1 2 3 4 5 6 8 11 12 13 14 16 18 19 20 23 26 28 33 37 38 39 42 44 45 47 50 51 52 53 56 57 58 61 62 63 64 65 69 77 81 84 86 10
6
10
8
5’ arm 3’ arm
Figure 1 | Targeted integration into COSMC locus using CRISPR/Cas9. (a) Schematic illustration of the targeting strategy for the specific locus of
interest. Donor plasmid consists of three parts: short homology arms flanking sgRNA target site cleaved by Cas9 (red triangle), mCherry and neomycin
resistance gene expression cassettes inside homology arms, and ZsGreen1-DR expression cassette outside homology arms. Upon DSBs induced by
CRISPR/Cas9, HDR-mediated repair can be used to insert a total size of 3.7 kb of expression cassettes through recombination of the target locus with
donor plasmids. Primer position for 59/39 junction PCR is indicated. (b) Agarose gel of 59/39 junction PCR on transiently transfected cells and stable cell
pools. An asterisk indicates the use of linearized donor plasmid. M, 1 kb DNA ladder (c) Sanger sequencing of the 59/39 junction PCR amplicons.
Amplicons from the stable cell pool were purified and directly sequenced after PCR amplification. The chromatogram sequence of junction PCR
amplicon was compared with the reference sequence at the genome-donor boundaries. (d) Agarose gel of out-out PCR results of stable cell pools or clonal
cells. Primer pairs annealing to genomic DNA region were used resulting in PCR products of either wild type (1.6 kb) or targeted integration (5.3 kb). (e)
Relative copy number of COSMC and mCherry regions in clonal cells. Each plot shows the relative copy number of each region in comparison to the
reference sample. Genomic DNA of wild type CHO-S and Clone #1 andwas used as the reference forCOSMC andmCherry region, respectively (shown in
red). The error bars represent the standard deviations (n $ 3).
www.nature.com/scientificreports
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to the Man5GlcNAc2 (Man5) N-glycan structure, Mgat1-disrupted
CHO cell lines are capable of producing recombinant proteins with
terminal mannose residues and show resistance to Ricinus communis
agglutinin-I (RCA-I), a cytotoxic lectin that binds Man5GlcNAc222.
In order to select efficient sgRNA target sites for the Mgat1 locus,
the indel efficiency of five sgRNAs was analyzed by deep sequenc-
ing (Fig. 2a). At post-transfection with Cas9 and sgRNA expression
vectors, the five tested sgRNAs generated detectable range of indels
from 10.0% to 20.7% in the Mgat1 locus (Fig. 2b). Two sgRNAs,
sgRNA1 and sgRNA5, were selected for targeted integration into the
Mgat1 locus. CHO-S cells were transfected with Cas9, sgRNA, and
donor plasmid to generate two cell pools, one for each sgRNA.
Junction PCR analysis of the stable selected pools were performed
(Fig. 2c, Lane 9–16) and compared with junction PCR analysis on
transiently transfected cells (Fig. 2c, Lane 1–8). Similar to the COSMC
locus, 59/39 junction PCR was only positive for the stable pools (Fig. 2c,
Lane 10 and 12 for sgRNA1 site; Lane 14 and 16 for sgRNA5 site).
Furthermore, stable cells expressing both mCherry and Zsgreen1-DR,
denoted by 11, showed less clean and intense bands than cells
expressing only mCherry, denoted by 1-, which indicated incomplete
integration (Fig. 2c, Lane 17–24). The sequencing results of 59/39
junction PCR amplicons confirmed precise gene insertion occurring
at the Mgat1 locus (Fig. 2d).
The amount ofMgat1-disrupted cells in two stable pools targeted for
either sgRNA1 or sgRNA5 site was estimated by analyzing fluorescein
labeled RCA-I (F-RCA-I) stained cells (Fig. 2e). In wild type CHO-S
cells, the majority of cells (. 94%) were stained with green fluorescent
F-RCA-I (Supplementary Fig. 2a). Likewise, the stable pools, only
transfected with donor plasmid, showed a complete shift from green
fluorescence negative (Q3 1 Q4) to green fluorescence positive popu-
lation (Q1 1 Q2) upon F-RCA-I staining, indicating that the majority
of cells have functional MGAT1 as expected. On the other hand, the
stable pools transfected with Cas9, sgRNA, and donor plasmid revealed
a fraction of 4.6–12.5% of green fluorescence negative cells regardless of
mCherry expression from donor plasmid, generating red fluorescence.
It demonstrated the presence of cells with knockout of theMgat1 gene
(Fig. 2e). Next, 59/39 junction PCR analysis was applied to evaluate the
percentage of target specific knock-ins following isolation of G418-
resistant and mCherry positive/ZsGreen1-DR negative clones. In con-
trast to the high efficiency observed in COSMC locus, we did not
obtain junction PCR positive clones, indicating very low efficiency
of targeted integration in the Mgat1 locus (Table 1). It is likely that
most cells belonging to red fluorescence positive/green fluorescence
negative (Q4) population upon F-RCA-I staining correspond to
mCherry expressors with NHEJ mutation in Mgat1 locus, and not
the targeted integrants. Hence, we used RCA-I lectin selection in order
to enrich forMgat1-disrupted clones occurred by targeted integration.
RCA-I treatment effectively induced cell growth arrest and subsequent
cell death in wild type CHO-S cells, implying RCA-I induced cyto-
toxicity (Supplementary Fig. 2b). 7 days post-RCA-I treatment, RCA-I
resistant cells grew to confluency only in the stable pools transfected
with Cas9, sgRNA, and donor plasmid (Supplementary Fig. 2c). F-
RCA-I staining of RCA-I enriched cell pools resulted in the major
fraction of green fluorescence negative cells preserved in the popu-
lation of Q3 1 Q4, indicating efficient enrichment for the Mgat1-
disrupted population (Fig. 2e). Deep sequencing of RCA-I enriched
pools confirmed this observation with indel frequencies of 83.5% and
99.0% for the sgRNA1 and sgRNA5 target sites, respectively
(Supplementary Fig. 2d). Thus, lectin selection can be applied to
increase the frequency of Mgat1-disrupted clones. RCA-I resistant
clones were then isolated from two RCA-I resistant stable cell pools
in order to analyze Mgat1 targeted integrants. 59/39 junction PCR
analysis of clonal cells revealed the presence of 32.3% and 27.1%
PCR positive clones for sgRNA1 and sgRNA5 target sites, respectively
(Table 1). Out-out PCR specific for two Mgat1 integration sites veri-
fied the correct targeting of target integration unit accompanying the
expected size of amplicons (wild type amplicon: 1.9 kb and 2.0 kb 1
target integration unit: 3.7 kb< 5.6 kb and 5.7 kb; Percentage of out-
out PCR positive clones from 59/39 junction PCR positive clones 5
90% and 100%, i.e. 29.0% and 27.1% in total; Fig. 2f, Lane 4 and 8,
Table 1). As a result, targeting efficiencies of 10.2% and 16.4% for the
sgRNA1 and sgRNA5 target sites respectively, were obtained
(Table 1). As observed in COSMC locus, Mgat1 locus was also com-
pletely disrupted in most targeted clonal cells (20 out of 25 clones),
which showed a relative Mgat1 copy number of close to 0 compared
with the Mgat1 in CHO-S wild type cells (Fig. 2g, left panel). The
mCherry gene dosage was found to be consistent amongst clones
except three clones, as shown by relative quantification of mCherry
gene (Fig. 2g, right panel). Precise targeted integration at the Mgat1
locus determined that this platform was not restricted to the COSMC
locus and/or COSMC-targeting sgRNA.
Application of targeted integration platform to the LdhA locus.
We also tested the current integration strategy on LdhA locus. LdhA
encodes the A subunit of lactate dehydrogenase that is responsible for
interconversion of pyruvate and lactate, one of the main accumulated
waste products during CHO cell culture. LdhA is therefore a pro-
mising metabolic target gene for knockout in order to enhance
culture performance. Five sgRNAs were designed for targeting exon
1, exon 3, exon 4, and exon 5 of the LdhA locus (Fig. 3a), followed by
deep sequencing analysis to compare the indel efficiency (Fig. 3b).
Indel frequencies were reported from 7.6% to 15.9%. Based on this,
sgRNA2 target site was selected for homology arm design and
integration site. Comparable to the previous loci tested, co-
transfection of the donor plasmid with Cas9 and sgRNA plasmid
resulted in precise targeted integration of donor DNA into the
LdhA locus. It was only observed in the stable selected pool as
determined by junction PCR analysis with expected DNA bases at
the genome-donor boundaries (Fig. 3c, Lane 6 and 8, Fig. 3d).
Amongst 61 isolated clonal cells, 10 clones were identified as both
junction PCR positive (16.4%, resulting in targeting efficiency of 7.4%,
Table 1). In contrast to relative copy number of COSMC and Mgat1
Table 1 | Summary of targeted integration
Target locus
Percentage of mCherry1/
ZsGreen1-DR- populationa (%)
Total clone number
(mCherry1/ZsGreen1-DR-)
59/39 Junction
PCR positive
Out/Out
PCR positivec
Targeting
efficiencyd (%)
COSMC 45.7 6 2.6 115 83 70 27.8
Mgat1b (Before RCA-I enrichment) 62.2 6 2.7/41.1 6 1.0 124/37 0/0 N/A N/A
Mgat1b (After RCA-I enrichment) 35.3 6 2.1/60.4 6 6.6 31/59 10/16 9/16 10.2/16.4
LdhA 45.2 6 2.9 61 10 N/A 7.4
aThe numbers indicate the percentage of mCherry1/ZsGreen1-DR- cell population in each stable cell pool measured by imaging cell cytometer. Average values from three independent experiments 6 SD
are shown.
bTwo numbers separated by diagonal lines indicate the results from two sgRNA target sites (sgRNA1/sgRNA5).
cPositive indicates expected size of PCR products occurring by targeted integration.
dTargeting efficiency was obtained by multiplying the percentage of mCherry1/ZsGreen1-DR- cell population by the percentage of out/out PCR positive clones amongst total mCherry1/ZsGreen1-DR-
clones investigated. In case of LdhA locus, out/out PCR results were not available. Therefore, 59/39 junction PCR results were used instead.
www.nature.com/scientificreports
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Figure 2 | Targeted integration into Mgat1 locus using CRISPR/Cas9. (a) Illustration of the five sgRNA target genomic sites inMgat1 locus. (b) Indel
frequency inMgat1 locus analyzed by deep sequencing. Genomic DNA was extracted 3 days after transfection with plasmids expressing Cas9 gene and
sgRNAs. The genomic regions covering sgRNA target sites were amplified, then subjected toMiseq analysis. The percentage of wt and indel sequences are
described in the bar plot. The values from control samples transfected only with plasmid expressing Cas9 were subtracted from test samples. (c) Agarose
gel of 59/39 junction PCR on transiently transfected cells and stable cell pools. (11) Stable cells expressing both mCherry and Zsgreen1-DR; (1-) stable
cells expressing onlymCherry. (d) Sanger sequencing of the 59/39 junction PCR amplicons. Amplicons from the stable cell pools were purified and directly
sequenced after PCR amplification. M, 1 kb DNA ladder. (e) Population analysis of Mgat1 disrupted cells by F-RCA-I staining. Based on red/green
fluorescence intensity of stable cell pools, which was further selected with RCA-I or not, alteration of fluorescence intensity was analyzed upon F-RCA-I
staining. Each scatter plot was divided by four quadrants, denoted byQ1 toQ4.Q3 andQ4 populations, marked by red squares, represent negative stained
cells with F-RCA-I, indicating functional knockout ofMgat1 locus. Numerals below the red squares show the percentage of Q3 and Q4. (f) Agarose gel of
out-out PCR results of stable pools or clonal cells. Primer pairs annealing to genomic DNA region were used resulting in PCR products of either wild type
(2.0 kb for sgRNA1 target site; 1.9 kb for sgRNA5 target site) or targeted integration (5.6 kb for sgRNA1 target site; 5.5 kb for sgRNA5 target site). (g)
Relative copy number of Mgat1 and mCherry regions in clonal cells, as described in Fig. 1(e). (Top) sgRNA1 target site (Bottom) sgRNA5 target site.
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locus, most LdhA targeted clonal cells (eight out of 10 clones) yielded a
partial number of relative LdhA copy number, indicating heterozygous
disruptions at the LdhA locus caused by monoallelic knock-ins
(Fig. 3e, left panel). Unexpectedly, two clones (clone #4 and #5) had
unmodified copy numbers of LdhA relative to CHO-S wild type cells,
probably due to non-clonal cell population or chromosomal
LdhA locus:
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Figure 3 | Targeted integration into LdhA locus using CRISPR/Cas9. (a) Illustration of the five sgRNA target genomic sites in LdhA locus. (b) Indel
frequency in LdhA locus analyzed by deep sequencing. Genomic DNA was extracted 3 days after transfection with plasmids expressing Cas9 gene and
sgRNA. The genomic regions covering sgRNA target sites were amplified, then subjected to deep sequencing analysis using Miseq. The percentage of
wt and indel sequences are described in the bar plot. The values from control samples transfected only with plasmid expressing Cas9 were subtracted from
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amplification. M, 1 kb DNA ladder. (e) Relative copy number of LdhA and mCherry regions in clonal cells, as described in Fig. 1(e).
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instability. Heterozygous modification at LdhA locus led to decrease in
mRNA expression levels of LdhA by approximately 50%, resulting in
reduction of protein expression levels as well (Supplementary Fig. 3).
Notably, deep sequencing analysis of nonintegrated allele revealed
evidence of in-frame deletions created in LdhA targeted clonal cells,
which is unlikely to lead to a loss-of-function (Supplementary Fig. 4).
As a result of heterozygous modification in LdhA locus, we could not
obtain expected size of PCR products from out-out PCR due to existence
of a residual allele. From analysis of the relative mCherry copy number,
similar results of consistent copy number across LdhA target clonal cells
were obtained (Fig. 3e, right panel). Targeted integration at the LdhA
locus was achieved using the current platform, which confirmed that this
method was also applicable at a diploid locus.
Off-target effects associated withCRISPR/Cas9mediated targeted
integration. To assess potential off-target mutations introduced by
the CRISPR/Cas9 activity, we first identified the most probable
potential off-target sites of each sgRNA target sequence within the
CHO genome. Prediction of off-target sites was based on three
criteria (see Methods section), followed by analysis of the NHEJ-
mediated indel frequencies at the on-target and off-target sites in
genomic DNA isolated from stable cell pools transfected with
Cas9, sgRNA, and donor plasmid by deep sequencing (Fig. 4). A
low level (, 0.5%) of off-target mutations were detected at all five
putative off-target sites for the COSMC sgRNA, despite high levels of
CRISPR/Cas9 activity at the corresponding on-target site, which
generated indels at frequencies of 56.8% (Fig. 4a). A similar off-
target tendency was observed for the Mgat1 sgRNA1, but unlike
sgRNA1, Mgat1 sgRNA5 displayed off-target indel generation at a
frequency of 10.7% at off-target 1 (Fig. 4b,c). RCA-I enrichment for
Mgat1-disrupted cells drastically increased an indel frequency from
16.4% and 37.3% to 83.4% and 98.9% at sgRNA1 and sgRNA5 on-
target sites (Fig. 4b,c), but did not induce additional off-target indel
mutations (Supplementary Fig. 5). Three out of four off-target sites
for the LdhA sgRNA displayed off-target activity (Fig. 4d). Sites
harboring one- or two-base mismatches contained indel mutations
at a frequency between 0.9% and 5.1%. Comparing the indel
frequencies observed at the off-target sites with those at the on-
target site, all on-target frequencies were 8.4-fold higher as a
minimum. Upon enrichment for positive integrant pools by RCA-I
selection, on-target to off-target frequency difference was greatly
increased from 9.3-fold to .10,000-fold (Fig. 4b,c). Due to these
on-target to off-target frequency differences, integration events at
the potential off-target sites will be less likely to occur. PCR amp-
lification of regions, covering off-target sites in mCherry positive/
ZsGreen1-DR negative targeted clones, showed no off-target integra-
tions, which supports this hypothesis (Supplementary Fig. 6). The low
mutation level of overall off-target sites supported the reliability of the
use of CRISPR/Cas9 system for targeted integration.
Correlation between targeted integration and homogeneous expres-
sion of GOI. To assess the effect of targeted integration on cell culture
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performance, differences in expression of mCherry and growth rates
between targeted integrants and random integrants were analyzed.
mCherry positive/ZsGreen1-DR negative cell population was isolated
from stable cell pool transfected with Cas9, sgRNA2, and donor
plasmid targeting COSMC locus by limiting dilution, then classified
as either targeted integrants or random integrants according to results
from 59/39 junction PCR and out-out PCR (Supplementary Fig. 7).
Both 59/39 junction PCR and out-out PCR positive clones were
defined as targeted integrants, and out-out PCR negative clones were
regarded as random integrants regardless of 59/39 junction PCR results.
Amongst positive targeted integrants, clones with complete disruption
at the COSMC locus and similar levels of relative mCherry copy
number were selected (Fig. 1e, n541). Cell growth and expression
level of GOI of the two populations was then compared. Both
populations displayed similar variations in the relative specific
growth rate (CV: 13.8% versus 12.4%; Fig. 5a). An average
expression level of targeted integrants was slightly lower than that
of random integrants (RFU average: 103 versus 140, p , 0.05;
Figure 5 | Effect of targeted integration on homogeneous expression of GOI. Targeted and random integrants isolated from the stable cell pool
transfected with Cas9, sgRNA, and donor plasmid targeting COSMC locus were cultivated to assess (a) RFU and (b) relative specific growth rate (m).
Average mean intensity of mCherry fluorescence measured by imaging cell cytometer was used for RFU. The specific growth rate was calculated from a
plot of viable cell concentration against culture time from day 0 to day 3. Eachmeasured value was normalized by that of the clone number 1. Center lines
show the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from
the 25th and 75th percentiles, outliers are represented by dots; data points are plotted as open circles. n 5 41, 40 sample points. Each sample point
represents average value of measurements at 3–5 different passages during cultivation for a month. (CV) coefficient of variation.
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Fig. 5b). Interestingly, targeted integrants displayed more stable
mCherry expression with 4.4-fold less variation than that of the
random integrants (CV: 14.3% versus 63.3%; Fig. 5b), indicating
more homogeneous and predictive expressions from site-specific
integration clones. The variability in expression levels of random
integrants was caused by the influence of both copy number and
integration site (Supplementary Fig. 8). Some of random integrants
with 2- or 3-fold higher copy number exhibited 2- or 3-fold higher
expression levels relative to the representative targeted integration
clone. On the other hand, various expression levels were observed
in a few random integrants despite similar levels of copy number.
Moreover, although the percentage of mCherry positive/ZsGreen1-
DR negative cells was initially close to 100% in all clones investigated,
it was notably decreased in some clones (five out of 40 clones, i.e. 12.5%
in total) only from the population of random integrants while cells were
expanding, underscoring unstable expression from random integration
(Supplementary Fig. 9). These data show that CRISPR and HDR
mediated targeted integration allowed stable and reproducible
transgene expression in rCHO cell lines without affecting cell growth.
Discussion
Site-specific integration of large transgenes during rCHO cell line
construction has been impeded by extremely low integration effi-
ciencies and specific requirements, including construction of plat-
form cell lines, which limit flexible targeting to any desired sites. Here
we developed a method for targeted integration by combining the
CRISPR/Cas9 system with a donor plasmid in CHO cells. The pro-
cedure allowed precise HDR-mediated integration of large gene
expression cassettes into desired sites with a targeting efficiency
between 7.4–27.8% depending on target locus and CRISPR/Cas9
activity. With the previous targeted integration studies in CHO cells
relying on the NHEJ pathway for integration of short (, 100 bp)
oligonucleotides16 or linear transgenes17, our approach is liberated
from the issues concerning orientation of transgene integration and
imperfect ligation caused by degradation of donor ends by exonu-
clease activity or end resection of the chromosome. Furthermore, we
report additional benefits common to the CRISPR/Cas9 system such
as high efficiency, robustness, simplicity, ease of design, and low cost.
Compared with the successful HDR-mediated integration of trans-
genes in human cells using the CRISPR/Cas9 system, which was
observed 72 hours after transfection14, we did not detect integration
events in transiently expressed cells, but only in stable selected pools
although transgene size and experimental conditions were different
(Fig. 1b, 2c, and 3c). This result supports intrinsically lower levels of
HDR-based transgenesis in CHO cells, which agrees with previous
studies16,17. In particular, the Mgat1 locus had non-appreciable fre-
quencies of integration before RCA-I enrichment, which showed the
locus-to-locus variation in terms of integration frequency (Table 1).
Although the CRISPR/Cas9 system generated indel mutations via
NHEJ with high efficiency between 16.4–56.8%, the rate of HDR-
mediated integration remained relative low (Fig. 4, Table 1). The
present targeting efficiency is sufficient for the generation of rCHO
cells when paired with drug or phenotypic selection, but requirements
for selection process can limit the practical application of targeted
integration at certain loci in an actual industrial production process.
However, the current method has sufficient room for further
improvement in targeting efficiency by implementing recent
advancements, such as rational design of highly active sgRNAs23,
enrichment of cells with genome editing events24, or construction
of expression vectors bearing both Cas9 and the sgRNA11 since the
CRISPR/Cas9 system is continuously undergoing optimizations to
improve activity. Transfection efficiency, which was measured based
on the fraction of mCherry positive/ZsGreen1-DR positive cells
72 hours post transfection, was in the range of 24.4–34.0% when
three plasmids, including donor plasmid, Cas9, and sgRNA plasmid,
were co-transfected. Compared with transfection efficiency of 33.0–
54.6% for control samples transfected with the donor plasmid only,
transfection of multiple plasmids lowered the transfection efficiency
considerably. Additionally, expression levels from separate constructs
may not be tightly coupled. This potential limitation can be overcome
by using the aforementioned single expression vector11 to drive both
Cas9 and sgRNA or FACS enrichment to aid selection of transfected
cells. As observed in the on-target indel efficiency in stable cells and
the targeting efficiency, the higher on-target indel efficiency is likely
to lead to higher HDR-mediated integration (Fig. 4, Table 1).
Therefore, the aforementioned approaches will aid in the increase
in current targeting efficiencies. Moreover, single-strand breaks
(SSBs) created by single sgRNA-Cas9 nickases have reported to be
capable of inducing homologous recombination in mammalian cells,
albeit at reduced frequency compared with wild-type Cas925,26. In
conjunction with improvements in targeting efficiency, targeted
integration via SSBs-induced homologous recombination will also
be an attractive strategy with regard to higher specificity and fidelity.
Previous studies have reported that the PAM-proximal 8–13 bp of
the target region is crucial for target recognition and cleavage by
Cas911,19, and within PAM-proximal region, a single-base mismatch
can be acceptable to conserve activity. Furthermore, up to three to five
mismatches in the PAM-distal region can be tolerated without
impairing the ability to cleave DNA27-29. More recently, genome-wide
mapping of Cas9 binding sites using catalytically inactive Cas9 and
ChIP-seq analysis has revealed that a 5-nucleotide seed region next to
PAM is required for Cas9 binding in vivo and in vitro30. Based on
this, we selected potential off-target sites for each target site to meet
these criteria, and evaluated off-target mutation rates (Fig. 4). Nine
out of 15 potential off-target sites were not affected. In four off-target
sites, we detected indels with a frequency of 0.5–1.3%, which was rare
enough to allow high fidelity of sgRNAs targeting on-target sites. The
last two off-target sites, however, contained detectable off-target cut-
tings at a frequency of 5.1% and 10.7%. A recent paper has suggested
that in addition to finding off-targets at sites with few mismatches
compared with the target sequence, off-targets may also be found at
sites with small inserts/deletions compared with the target sequence
under certain circumstances31. This type of off-targets have not been
considered in the current work, but guide RNA design in the future
should aim to identify such additional potential off-target sites so that
appropriate care may be taken. Off-target mutations may not be
critical to rCHO cell line construction compared with human gene
therapy. However, potential problems in connection with off-target
mutations could cause unpredictable toxic effects. This latent obstacle
could also be mitigated by using approaches to improve on-target
specificity of Cas9, such as the double-nicking approach26,29, truncated
guide RNAs32, or dimeric CRISPR RNA-guided FokI nucleases33.
Cultivation of targeted integrants displayedmore stable and highly
reproducible expression levels when compared with random inte-
grants. Although this result demonstrates the minimal variability in
expression level, it is limited to the specific locus and expression
cassette. The expression level can depend on the target locus and
the cassette design, particularly relating to the promoter used and
its susceptibility to silencing. Thus, additional studies in various loci
with different transgene expression cassettes are warranted to con-
firm the generality of this finding. Despite homogeneous transgene
expression levels in targeted integrants, some of the random integ-
ration clones exhibited 2- or 3-fold higher expression levels relative
to representative targeted integration clone (Fig. 5b, Supplementary
Fig. 8). These observations were due to random integration into
highly active chromosomal regions with the CHO genome or integ-
ration of several copies of the donor plasmid. Given that the ultimate
goal for construction of production cell lines is rapid generation of
high and stable producers, ensuring comparable quality for regula-
tory approval, the selection of ideal transgene insertion sites is highly
demanded. Ideal insertion sites, also called ‘Safe harbors’ or ‘Hot
spots’, should allow high and stable transcription/expression levels
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8572 | DOI: 10.1038/srep08572 9
of the GOI without perturbing essential regulatory elements or dis-
rupting genes which are responsible for the quality of the products.
Previous extensive studies on the selection and identification of
desirable target sites in human cells provide reliable guidelines to
facilitate rapid identification of such ‘‘hot spots’’ in CHO cells13,34.
A further refinement of existing Chinese hamster reference genome
and all of the relevant sequence information of CHO host cell lines,
together with new data on genome stability at the chromosomal level
will facilitate identification of potential target sites as well as a better
characterization of the current targeted integration strategy. Moreover,
a recent study demonstrated that actively transcribed chromatin struc-
ture was preferentially repaired by homologous recombination over
NHEJ upon DSB35. This trait fits perfectly into the presented platform
and will reinforce the targeting efficiency. Thus, this approach should
be able to provide a valuable genetic tool to characterize different
potential good integration sites in CHO cells, ultimately leading to a
rational construction of production cell lines assuring sustainable and
high expression levels.
Methods
Plasmid design and construction. The CHO codon optimized Cas9 expression
vector and sgRNA expression vector applied in this study were constructed as
described previously20. The CRISPy bioinformatics tool20 was applied for generating
sgRNA target sequences (Supplementary Table 1). Subsequently, single stranded
oligos comprising the variable region of the sgRNA (Supplementary Table 2) were
synthesized, annealed, and mixed with the expression vector backbone harboring U6
promoter, scaffold RNA sequence, and termination sequence to generate sgRNA
expression vectors.
Donor plasmids were constructed with uracil-specific excision reagent (USER)
cloning method according to Ref. 36. The different parts of the plasmid were amp-
lified with uracil-containing primers and proofreading polymerase PfuX7. 59 and 39
homology arms flanking each sgRNA target sequence were amplified from genomic
DNA of CHO-S cells, which were extracted by GeneJET Genomic DNA Purification
Kit (Thermo Fisher Scientific, Waltham, MA). EF-1a promoter, NeoR expression
cassette (pSV40-NeoR–SV40 pA), and expression vector backbone parts were
directly amplified from commercial expression vectors, but ZsGreen1-DR expression
cassette (pCMV-ZsGreen1-DR-BGH pA) and mCherry-BGH pA parts were amp-
lified from pre-assembled expression vectors that were constructed with USER
cloning method using commercial expression vectors. Primer sequences and all
plasmids used as PCR templates are listed in Supplementary Table 2 and 3, respect-
ively. Following purification of PCR products by agarose gel separation and
NucleoSpinH Gel and PCR Clean-up kit (Macherey-Nagel, Du¨ren, Germany), the
purified 7 PCR fragments including both homology arms, EF-1a promoter, mCherry-
BGH pA, NeoR expression cassette, ZsGreen1-DR expression cassette, and backbone
were assembled with USER enzyme (New England Biolabs, Ipswich, MA) and
transformed into E. coliMach1 competent cells (Life Technologies, Leuven, Belgium).
Plasmids were harvested from transformants selected on LB agar plates with ampi-
cillin. All constructs were verified with sequencing and purified using NucleoBond
Xtra Midi EF (Macherey-Nagel) according to manufacturer’s instructions.
Cell culture, transfection, and stable cell line construction. CHO-S cells from Life
Technologies were grown in CD CHO medium supplemented with 8 mM L-
Glutamine (Life Technologies) and cultivated in a 125-mL Erlenmeyer flask (Sigma-
Aldrich, St. Louis, MO) with a working volume of 30 mL. The cells were incubated at
37uC, 5% CO2 with 120 rpm shaking and passaged every 3 days. Cells were
transfected with expression vectors encoding CHO codon optimized Cas9, sgRNA
targeting the integration site and corresponding donor plasmid. For each sample, 33
106 cells were transfected with a total of 3.75 mg of DNA using FreeStyleTM MAX
reagent together with OptiPRO SFM medium (Life Technologies) according to
manufacturer’s recommendations. 16 hours post transfection, the samples were
incubated at 30uC for 32 hours before transferred back to 37uC.
Stable cell pools were generated by seeding cells in CELLSTARH 6 well Advanced
TC plates (Greiner Bio-one, Frickenhausen, Germany) on day 3 followed by selection
process under G418 (500 mg/mL; Sigma-Aldrich). During selection, medium was
changed every 3–4 days. After 2 weeks of selection, cells were detached with TrypLE
(Life Technologies) and adapted to grow in suspension in non-tissue treated plates or
Erlenmeyer flask depending on cell concentrations. For clonal selection, limiting
dilution step was followed using the stable cell pools, which were either bulk sorted for
mCherry positive/ZsGreen1-DR negative cell population using a BD FACSJazz cell
sorter (BD Biosciences, San Jose, CA) or not. 1 cell was seeded per well in 200 ul
medium in 96 well plates. The generated colonies were analyzed by a Celigo Imaging
Cell Cytometer (Nexcelom Bioscience, Lawrence, MA) applying the Direct cell
counting application to check for single colonies. Only the wells with round shaped
colonies expressing mCherry were selected for further analysis.
Genomic DNA extraction and PCR amplification. Genomic DNA was extracted
from the cell pellets using QuickExtract DNA extraction solution (Epicentre,
Illumina, Madison, WI) or GeneJET Genomic DNA Purification Kit depending on
the purpose of experiment. For single cell clones, DNA was isolated by adding 20 mL
of QuickExtract DNA extraction solution when cells were confluent in 96 well plates.
The mixture was then incubated at 65uC for 15 min, followed by 5 min incubation at
98uC. Of this mixture, 1–2 mL were used as template for junction PCR and out-out
PCR, as described below. For the other experiments, GeneJET Genomic DNA
Purification Kit was used to extract DNA from cell pellets up to 5 3 106 cells
according to manufacturer’s instructions. 59/39 junction PCR was carried out using
DreamTaq DNA polymerase (Thermo Fisher Scientific) by touchdown PCR (95uC
for 2 min; 103: 95uC for 30 s, 68uC–58uC (21uC/cycle) for 30 s, 72uC for 2 min;
203: 95uC for 30 s, 58uC for 30 s, 72uC for 2 min; 72uC for 5 min). Out-Out PCRwas
performed using Phusion Hot Start II High-Fidelity DNA Polymerase (Thermo
Fisher Scientific) by touchdown PCR (98uC for 30 s; 203: 98uC for 10 s, 64uC–54uC
(20.5uC/cycle) for 30 s, 72uC for 3 min; 303: 98uC for 10 s, 54uC for 30 s, 72uC for
3 min; 72uC for 10 min). PCR primers are listed in Supplementary Table 2.
Deep sequencing analysis. Deep sequencing was performed on a MiSeq Benchtop
Sequencer (Illumina, San Diego, CA). Libraries were prepared based on Illumina ‘16S
Metagenomic Sequencing Library Preparation’ with some modifications. Genomic
regions flanking target genomic sites were amplified using Phusion Hot Start II HF
Pfu polymerase (Thermo Fisher Scientific) by standard PCR (98uC for 30 s; 253:
98uC for 10 s, 59uC for 30 s, 72uC for 30 s; 72uC for 10 min), with primers containing
overhang sequences compatible with Illumina Nextera XT indexing (forward primer
overhang: TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG, reverse primer
overhang: GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG). PCR primers
are listed in Supplementary Table 2. After PCR amplification, amplicons were
purified using AMPure XP beads (Beckman Coulter, Brea, CA). Illumina Nextera XT
Index (Illumina # FC-131-1001) sequencing adapters were integrated into the
amplicons by PCR (98uC for 3 min; 83: 95uC for 30 s, 55uC for 30 s, 72uC for 30 s;
72uC for 5 min). The final libraries were purified with AMPure XP beads before
quantification. The purified libraries were quantified using the QubitH dsDNA BR
Assay Kit (Life Technologies), and the product size within the library was verified by
2% agarose gel. Sequencing was performed as a 151 paired-end run. Sequence data
was analyzed using custom python code that compared the sequence data with the
expected wild-type sequence from the CHO genome20. In short, it first paired the
paired end fastq sequence files. Then, it de-multiplexed the sequence reads based on
59 or 39 similarity to the expected wild-type sequence followed by detection of
potential indels to categorize sequences as either wild type or indel-containing. The
final product of these steps is a list for each target or off-target with numbers for how
often we see the wild type and how often we see indels and the size of these indels.
Batch culture. Exponentially growing cells were inoculated at a concentration of 3.0–
4.0 3 105 cells/mL into Polystyrene transparent square 96-half-deepwell microplates
with Sandwich cover (Enzyscreen, Leiden, Netherlands) containing 250–300 mL of
culture medium, and the culture plates were then incubated on the Multitron cell
(INFORS HT, Bottmingen, Switzerland) at 350 rpm in humidified 5% CO2 at 37uC.
Viable cell concentration was estimated using PrestoBlueH Cell Viability Reagent
(Life Technologies) according to manufacturer’s instructions. Briefly, 10 mL of
PrestoBlue reagent was directly added to 90 mL of themixture of cells andmedia in 96
well plates. The plates were incubated for . 30 minutes at 37uC, and then
fluorescence was measured by microplate reader (Synergy Mx, BioTek Instruments,
Inc., Winooski, VT). The resulting fluorescence intensity was used to determine
viable cell concentration based on the standard curve created with CHO-S cells. On
day 3 after a new passage, cells were incubated with NucBlueH Live ReadyProbesH
Reagent (Life Technologies) for 20 minutes, and red and green fluorescence was
measured by a Celigo Imaging Cell Cytometer using the mask 1 target 1 1 target 2
application. Cells were identified using the blue fluorescence channel asmask, and the
red and green fluorescent channels were used as target 1 and target 2, respectively. For
cytometer analysis, about 10,000–20,000 cells were used per sample.
Ricinus Communis Agglutinin-I (RCA-I) selection and phenotypic analysis of
Mgat1 knockout cells.Mgat1 knockout cells were enriched in culture medium with
5 mg/mL of RCA-I (Vector Laboratories, Peterborough, UK) using the stable cell
pools. After 7 days of selection, cells were adapted to grow in suspension, followed by
phenotypic analysis. Cells were stained with NucBlueH Live ReadyProbesH Reagent
with and without fluorescein labeled RCA-I (F-RCA-I, Vector Laboratories) at final
concentration of 20 mg/ml for 45 min at RT. Cells were then washed three times with
fresh culture medium and medium was completely removed. Celigo Imaging Cell
Cytometer was used to measure fluorescence using the mask 1 target 1 1 target 2
application as described earlier.
Off-target prediction. Off-targets were predicted using custom python code that
compared the targets with all other potential targets in the CHO genome. Off-targets
were then scored based on the following criteria: i) The first 5 bp immediately
adjacent to the PAM sequence: cutoff value of 0; ii) The number of mismatches in the
first 13 bp: cutoff value of up to 1; iii) The total number of mismatches including
number of mismatches in first 13 bp: cutoff value up to 5.
Quantitative Real Time PCR (qRT-PCR) for copy number analysis. For relative
determination of copy number of transgene, qRT-PCR was performed on genomic
DNA samples using Brilliant III Ultra-Fast SYBRHGreen QPCRMaster Mix (Agilent
Technologies, Santa Clara, CA) on Mx3005P qPCR System (Agilent Technologies)
www.nature.com/scientificreports
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according to manufacturer’s instructions. Reaction mixtures contained SYBR Green
QPCRmaster mix, 250 nM of forward and reverse primers, reference dye, and 20 ng
of genomic DNA. Amplificationwas executed with the following conditions: 95uC for
10 min; 403: 95uC for 20 s, 60uC for 30 s. The primers were designed using
PrimerQuest (Integrated DNA Technologies, Coralville, IA) against transgene
encompassing EF-1a –mCherry, target genes includingCOSMC,Mgat1 (sgRNA1 and
sgRNA5 target site), and LdhA, and reference gene, Vcl (Supplementary Table 2). All
primers were validated empirically by melting curve analysis and agarose gel
electrophoresis. Standard curves generated with 4-fold serial dilutions of genomic
DNA samples over 5 grades showed a good linearity (r2 . 0.98) and acceptable
amplification efficiencies between 90% and 110% for all primer pairs. Each PCR
reaction included no template controls in every PCR running, and had 3 replicates
with 2 times repetition. Using a delta-delta threshold cycle (DDCT) method37, relative
copy number was estimatedwith respect to wild type CHO-S cells for target genes and
representative clones for mCherry transgene.
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